Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Secondary Prevention of Depression Through Group-based Acceptance and Commitment Therapy Preceded by an Experimental Attentional Bias Modification Procedure

NCT02648165 is registered in ClinicalTrials.gov with Sorlandet Hospital HF as lead sponsor.

NCT NCT02648165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02648165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Secondary Prevention of Depression Through Group-based Acceptance and Commitment Therapy Preceded by an Experimental Attentional Bias Modification Procedure
Lead sponsor
Sorlandet Hospital HF
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2015
Completion date
November 30, 2018
Enrollment
224 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

major depression